Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2023 | 02-2023 | 11-2022 | 08-2022 | 05-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,048 | 11,110 | 2,603 | 4,676 | 4,231 |
| TOTAL | $10,805 | $14,110 | $6,551 | $9,857 | $10,515 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 487 | 532 | 523 | 18,537 | 18,670 |
| TOTAL | $487 | $532 | $523 | $18,537 | $18,670 |
| Total Assets | $11,292 | $14,642 | $7,074 | $28,394 | $29,185 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 62,725 | 62,667 | 67,187 | 68,991 | 67,974 |
| Accrued Expenses | 22,575 | 22,654 | 18,572 | 16,495 | 18,946 |
| Other current liabilities | 79 | N/A | N/A | N/A | N/A |
| TOTAL | $119,796 | $121,334 | $122,690 | $122,319 | $123,161 |
| Non-Current Liabilities | |||||
| Long Term Debt | 714 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 283 | 318 | 353 | 387 | 422 |
| TOTAL | $997 | $318 | $353 | $387 | $422 |
| Total Liabilities | $120,793 | $121,652 | $123,043 | $122,706 | $123,583 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 930,960 | 912,513 | 832,971 | 812,825 | 810,720 |
| Common Shares | 919 | 837 | 825 | 813 | 720 |
| Retained earnings | -841,690 | -823,054 | -809,352 | -782,857 | -766,131 |
| TOTAL | $-109,501 | $-107,010 | $-115,969 | $-94,312 | $-94,398 |
| Total Liabilities And Equity | $11,292 | $14,642 | $7,074 | $28,394 | $29,185 |